The Eijkman Institute for Molecular Biology (PRBME) is following up on and supporting the development and preparation ...
The COVID-19 pandemic has wreaked havoc globally, including in Indonesia. It has claimed many lives, increased the ...
Research to develop the Merah Putih (Red and White) vaccine for COVID-19 is a milestone in Indonesia's research and ...
The participants of the Merah Putih (Red and White) vaccine’s clinical trial will be observed for one year, lead ...
The first phase clinical trial of the domestically-produced Merah Putih vaccine is a huge leap for independent vaccine ...
A recent announcement that the Red and White vaccine is expected to be ready for production by mid-2022 offers hope to ...
The National Research and Innovation Agency (BRIN) has signed a licensing cooperation agreement with a private ...
Development of the Red and White vaccine to handle COVID-19 remains a priority in the National Research and Innovation ...
The National Research and Innovation Agency (BRIN) has said that seven teams are currently developing indigenous ...
The integration of non-ministerial government agencies and research and development units of ministries and agencies ...
An expert at the National Research and Innovation Agency (BRIN) pressed for further improving the ability to trace ...
Breaking the chain of COVID-19 transmission could prevent mutation of the SARS-CoV-2 virus that could produce new ...
Indonesia needs to intensify contact tracing and mass testing among communities to curb a potential resurgence in ...
It is hoped that the recent merger of the Eijkman Institute for Molecular Biology with the National Research and ...
The National Research and Innovation Agency (BRIN) has said it will work on developing the Merah Putih vaccine and a ...